Document Detail


Effect of treatment with magnesium and potassium on mortality and reinfarction rate of patients with suspected acute myocardial infarction.
MedLine Citation:
PMID:  8738859     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of the study was to test whether magnesium and potassium administration can decrease both early and late cardiac event rates in 355 patients with suspected acute myocardial infarction (AMI). The study was conducted by a primary and secondary care research centre as a randomized, initially double-blind comparison for 4 weeks followed by a single blind period for 2 years. Patients with definite or possible AMI and unstable angina based on World Health Organization criteria were assigned within 24 hours of infarction to different groups. Treatment was administered for 3 days through intravenous infusion with either 8.12 mmol/day Mg (group A, n = 81), 10.49 mmol/day K (group B, n = 77) 10% dextrose solution (group C, n = 87) or a placebo containing 2% dextrose solution (group D, n = 81). After discharge from the hospital all groups were advised to follow a fat-reduced diet. Groups A, B, and C were also advised to take magnesium hydroxide or potassium chloride orally. Comparison of groups A and B with group D over 2 years indicated that treatment with magnesium or potassium was associated with increased (p < 0.05) serum magnesium and potassium, and significant reduction in the incidence of cardiac events (22 and 24 vs 41 patients), total mortality (9 and 10 vs 20 deaths), and ventricular ectopics (17 and 21 vs 44), respectively, in the groups. Group C showed no significant benefit. It is possible that magnesium and potassium infusion immediately after AMI and addition of Mg and K salts to the AMI regimen may enhance tissue levels of these cations, leading to significant reduction in complications and mortality after 2 years.
Authors:
R B Singh; N K Singh; M A Niaz; J P Sharma
Related Documents :
18412239 - Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: propen...
17307419 - Intracoronary beta-irradiation for the treatment of de novo lesions: 5-year clinical fo...
22947159 - Clinical and clinicopathologic abnormalities in young dogs with acquired and congenital...
22036539 - Arthroscopic treatment of septic arthritis of the elbow.
25016269 - The role of ki-67 in women with a resistant prolactinoma: a retrospective analysis in 1...
20850089 - Thrombosis of second-generation drug-eluting stents in real practice results from the m...
19567759 - Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery.
11552889 - Stent placement in short unilateral iliac occlusion. technique and 24-month results.
2619149 - The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mas...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  International journal of clinical pharmacology and therapeutics     Volume:  34     ISSN:  0946-1965     ISO Abbreviation:  Int J Clin Pharmacol Ther     Publication Date:  1996 May 
Date Detail:
Created Date:  1996-10-25     Completed Date:  1996-10-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9423309     Medline TA:  Int J Clin Pharmacol Ther     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  219-25     Citation Subset:  IM    
Affiliation:
Heart Research Laboratory, Medical Hospital and Research Centre, Moradabad, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Aspartate Aminotransferases / blood
Blood Pressure / physiology
Creatine Kinase / metabolism
Double-Blind Method
Electrocardiography
Female
Humans
L-Lactate Dehydrogenase / blood
Magnesium / therapeutic use*
Male
Middle Aged
Myocardial Infarction / mortality,  physiopathology,  prevention & control*
Potassium / therapeutic use*
Recurrence
Risk Factors
Smoking
Chemical
Reg. No./Substance:
7439-95-4/Magnesium; 7440-09-7/Potassium; EC 1.1.1.27/L-Lactate Dehydrogenase; EC 2.6.1.1/Aspartate Aminotransferases; EC 2.7.3.2/Creatine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activation of protein tyrosine kinase: a possible requirement for fixed-bacteria and lipopolysacchar...
Next Document:  Establishment of a reliable extraction method of estrone sulfate from bovine plasma for detection of...